Head-To-Head Comparison: Teladoc Health (TDOC) & Its Rivals

Teladoc Health (NYSE:TDOC) is one of 95 publicly-traded companies in the “Medical Services” industry, but how does it compare to its rivals? We will compare Teladoc Health to related businesses based on the strength of its profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

Analyst Ratings

This is a breakdown of current recommendations for Teladoc Health and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	0	12	7	0	2.37
Teladoc Health Competitors	424	2257	4833	156	2.62

Teladoc Health currently has a consensus target price of $9.65, suggesting a potential upside of 15.81%. As a group, “Medical Services” companies have a potential upside of 475.16%. Given Teladoc Health’s rivals stronger consensus rating and higher possible upside, analysts plainly believe Teladoc Health has less favorable growth aspects than its rivals.

Valuation and Earnings

This table compares Teladoc Health and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Teladoc Health	$2.57 billion	-$1.00 billion	-1.41
Teladoc Health Competitors	$12.97 billion	$235.02 million	6.26

Teladoc Health’s rivals have higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Teladoc Health has a beta of 1.84, meaning that its share price is 84% more volatile than the S&P 500. Comparatively, Teladoc Health’s rivals have a beta of 1.66, meaning that their average share price is 66% more volatile than the S&P 500.

Profitability

This table compares Teladoc Health and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-39.66%	-11.01%	-4.66%
Teladoc Health Competitors	-746.47%	-28.20%	-12.45%

Insider and Institutional Ownership

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 57.3% of shares of all “Medical Services” companies are owned by institutional investors. 0.6% of Teladoc Health shares are owned by insiders. Comparatively, 13.0% of shares of all “Medical Services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Teladoc Health rivals beat Teladoc Health on 8 of the 13 factors compared.

About Teladoc Health

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.